§ Funding Round
Series B funding round for Visen Pharmaceuticals raising $150M in January 2021
Series B funding round for Visen Pharmaceuticals raising $150M in January 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Angel | michael wolff jensen | |
| Organization | — | |
| Organization | — | |
HBM Healthcare Investments | — | — |
Hongshan Capital Group (Sequoia Capital China)LEAD | — | — |
Logos Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
Visen Pharmaceuticals raised $150M in a Series B round.
The round was announced on 01/01/21.
The round was led by Hongshan Capital Group (Sequoia Capital China).
